Fig. 3From: Chemoradiotherapy is an alternative choice for patients with primary mediastinal seminomaLocal regional relapse-free survival (LRFS) (A), distant metastasis-free survival (DMFS) (B), and progression-free survival (PFS) (C) of patients according to Masaoka stageBack to article page